Small Molecule Drug Substance

Eurofins CDMO Alphora is a Canadian contract development and manufacturing organization (CDMO) with FDA- and Health Canada-inspected facilities, providing comprehensive development and manufacturing solutions for small molecule drug programs. Our expertise spans process development, process optimization, analytical method development and validation, and both non-GMP and GMP manufacturing for complex active pharmaceutical ingredients (APIs), including highly potent compounds.

From early-stage development through commercial production, we partner with sponsors to advance programs efficiently and confidently. Our integrated scientific and manufacturing capabilities support critical IND-enabling activities, scale-up, technology transfer, regulatory submissions, and commercial supply, helping to streamline development timelines while maintaining the highest standards of quality and compliance.

With extensive experience in handling challenging chemistries and complex synthetic processes, we deliver tailored solutions designed to accelerate development, mitigate risk, and support successful progression from preclinical studies to market.